Saturday 17 October 2026
Export MTVA’s income statement to Excel — free account
MetaVia Inc.
MTVA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 68.5% and free cash flow fell 22.4%, each against the same quarter a year earlier.
1.26
0.11
−8.03%
Follow MTVA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(168.18%) | (195.61%) | (195.12%) | (175.68%) | |
| (87.87%) | (94.75%) | (99.00%) | (91.06%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(260.12%) | (247.39%) | (146.13%) | (214.68%) | |
Free Cash Flow per Share |
(7.35) | (8.89) | (3.12) | (2.67) | |
Free Cash Flow |
(16.31) | (15.70) | (15.14) | (15.83) | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(79.15%) | (100.59%) | (66.41%) | (81.39%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.01 | 1.21 | 1.15 | 1.10 | |
Depreciation/Fixed assets |
0.86 | 1.12 | 1.67 | 2.38 | |
Capex/Depreciation |
(0.11) | (0.11) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(7.35) | (8.89) | (3.12) | (2.67) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates